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Abstract:  Systemic lupus erythe-
matosus is an autoimmune multi-
systemic inflammatory disease 
that is rare in children. Though a 
disease of the black race it is 
rarely diagnosed in black African 
children. Only few cases have 
been report in Nigeria and these 
were in the south. We report a 
case of a 7-year-old girl who pre-
sented with recurrent body swell-
ings, an unusual rash, pericardial 
effusion and gastro-intestinal dis-
turbances. The diagnosis was 
made after serology was found to 
be positive for Anti-nuclear anti-
body (ANA). She later developed 
stroke which was characterized by 
a convulsive episode, loss of con-
sciousness and subsequent right-
sided hemiplegia. She gradually 
regained consciousness after three 
days with residual weakness of the 
right side of her body. She has 
commenced prednisolone and is 
currently on follow-up at our 
clinic.SLE though rareshould be 
considered in any child with multi-
organ disease, nephritis or stroke, 
especially after common condi-
tions in our environment have 
been excluded. 
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Systemic Lupus Erythematosus (SLE) is a chronic multi
-systemic autoimmune connective tissue disease1. It was 
first described by Rogenius in the 13th century when he 
coined the word “lupus”meaning “wolf bite”2. It is char-
acterized by periods of increased disease activity (flares) 
and then remission1. Its incidence increases with age and 
it has a remarkable predilection for the females, espe-
cially after puberty1,3. SLE is prevalent among black 
children resident in Europe and America but rare among 
blacks in Africa1-3. It is very uncommon in the first dec-
ade of life and only 20% of all cases occur in the second 
decade1 therefore many paediatricians miss the diagnosis 




A 7-year-old girl was first seen at the Paediatric Out-
Patient Department (POPD) of the Aminu Kano Teach-
ing Hospital (AKTH) 5weeks prior to her admission. 
She presented with recurrent facial and abdominal swe l-
ings (Fig.1) for the past one year. The facial swelling 
would improve as the day went by. The abdominal 
swelling was associated with easy satiety. There was no 
swelling of her feet and she had no urinary symptoms. 
She had no abdominal pain or difficulty with breathing. 
She had no history of jaundice, sore throat, joint pain or 
swelling. There was no history of blood transfusion, 
cough or changes in her behavior or school performance. 
An initial abdominal ultrasound showed bilaterally 
enlarged kidneys and urine culture had a positive growth 
for Escherichia coli sensitive to cefixime. Cefixime was 
given at 100mg twice daily and she was also given fu-
rosemide at 20mg twice daily. Thereafter, she developed 
facial rash which later progressed to involve the trunk, 
extremities and lower lip. The rashes were itchy and 
more on the sun-exposed parts of her body.  
 
 
Fig 1: Peri-orbital 









The urinalysis showed proteinuria (2+) and hematuri 
(1+) and her electrolytes, blood urea nitrogen, 
creatinine, lipid profile, liver enzymes were essentially 
normal (Tab. 1.0).  
One week later, she was rushed into our Emergency 
Paediatric Unit (EPU) with complaints of recurrent 
vomiting and abdominal pain which started two days 
prior. She had two episodes of similar complaints twice 
in the preceding month but not severe enough to warrant 
admission. At presentation, she had multiple bouts of 
copious coffee-ground vomitus and was weak, sweaty 
and cold. The rashes had worsened, despite withdrawal 
of her medications (cefixime and furosemide). She had a 
normal height of 115cm (above the 3rd centile for age) 
and weight of 25kg (above the 3rd centile). There were 
widespread doughnut-shaped, target-like maculopapular 
rashes with erythematous border on the face, upper trunk
and upper and lower limbs with relative sparing of the
extensor aspect of the upper limbs and flexor aspect of 
the lower limbs, pulses were feeble and regular, blood 
pressure on the right arm in sitting position was 
80/50mmHg (<50thcentile for gender, age and height), 
jugular venous pressure was not elevated, apex was dif-
fuse and she had muffled first and second heart sounds, 
no added sounds. Abdomen was distended with as cites 
demonstrable by shifting dullness. There was hepa-
tomegaly with liver span of 14cm, firm and non-tendr, 
no ballotable kidneys. While on admission she devel-
oped fever, worsening of abdominal pain, therefore 
spontaneous bacterial peritonitis was considered. 
 
An urgent abdominal ultrasound confirmed marked as-
cites, chest radiograph showed enlargement and globular 
appearance of the cardiac silhouette (CTR=0.72) with 
apparently clear lung field. Electrocardiography showed 
low-voltage waves with no rhythm abnormality and 
echocardiography revealed moderate pericardial effu-
sion with normal systolic function (Fig. 2). A repeat 
dipstick analysis showed moderate proteinuria (2+), 
hematuria (1+) with no other abnormality. 
 
 





















Full Blood Count (FBC) showed relative lymphocytosis, 
and platelet count was normal (Tab. 1.0), mantoux test
was non-reactive, erythrocyte sedimentation rate was 
slightly elevated(35mm/hr), sputum for Acid fast bacilli 
was negative and ascitic tap yielded no organism with 
normal cell count and glucose, Serum-Ascites Albumin 
Gradient (SAAG) was 2.5g/dl (transudative). Serologic 
investigations for hepatitis and HIV were negative and 
Anti-Nuclear Antibodies (ANA) assay was requested. 
While awaiting the result she was placed on 1g of ceftri-
axone twice daily, intravenous furosemide (2mg/kg/day 
in two divided doses) and spironolactone (12.5mg twice 
daily) and intravenous fluid for the persistent vomiting, 
intravenous cimetidine (200mg twice daily) was also 
added and pentazocine (1.5mg/kg thrice daily) given for 
abdominal pain. Review of ANA result (6.5 which is 
above lab reference of 1.2) led us to a diagnosis of Sys-
temic Lupus Erythematosus when combined with three 
other criteria that she had fulfilled viz; serositis, rashes 
and nephritis. She was commenced on high dose predni-
soloneat 1mg/kg/day, aspirin and sunscreen lotion while 
awaiting renal biopsy and ophthalmologic examination 
prior to commencing hydroxychloroquine. She im-
proved and was discharged to clinic for follow up. A 
week later, she developed another episode of vomiting, 
abdominal pain and subsequently had an episode of gn-
eralized convulsion associated with loss of conscious-
ness and right-sided body weakness which was worst at 
onset. Computerized Tomograph (CT) of the brain 
showed a large left hemispheric infarct. Subsequently, 
she improved regained of consciousness but had resiual 
aphasia and right-sided hemiparesis. She is still on pred-
nisolone and has commenced physiotherapy  
 
Summary of some essential investigations 
Parameter                                    Result                   Normal Range 
Complete blood count 
Packed cell volume(%)               30.6                          35-50 
White cell count 
 Total /mm3                                 7000                         4000-11,000 
Neutrophils/mm3                         2300                        1500-7000 
Lymphocytes/mm3                      4000                        1000-3700 
Platelet count/mm3                      403 x 103                 150-450x103 
Ascitic fluid 
Protein (g/l)                                 43
Glucose (g/dl)                             0.5 
WCC  (/mm3 )                             50 
Liver Function tests(U/L) 
Enzymes 
ALP                                            10                            42-110 
ALT                                             3                               4-34 
AST                                             2                            7-45 
Bilirubin-Total  (µmol/L)            10                             4-18 
Direct (µmol/L)                           3                               0-7 
Serum Protein( g/l) 
Total                                           68                             59-86 
Albumin                                      36                         32-51 
Globulin                                      32                          20-43 
Clotting Profile 
PT                                               13s                            13-16s 
PTTK                                          36s                            35-43s 
Blood chemistry 
Urea (mmol/L)                            6.7                       2.1-6.9 
Sodium(mmol/L)                        137                      130-146 
Potassium (mmol/L)                   3.6                       3.0-5.6 
Bicarbonate (mmol/L)                25                              20-28 
Chloride (mmol/L)                     97                         94-108 
Creatinine (µmol/L)                   85                         30-111 
Lipid Profile(mmol/L) 
Total chol.                                   2.8                          2.5-6.4 
HDL                                            0.8                           0.8-2.6 
LDL                                            1.54                           0.8-4.3 
TRIG                                           0.8                           0.5-2.8 
Urine Microscopy 
Pus cells                                      2
Epithelial cells                           Scanty 





Systemic Lupus Erythematosus is uncommon in chil-
dren and rarer in African black children with only few 
case reports4.  Less than 10% of SLE cases worldwide 
are diagnosed in the first decade1. Our patient presented 
at the age of 7 years which is comparable to the median 
age (9.2years) at diagnosis among Indian children2. 
However, Olowu5 in Ile-Ife (Southwest Nigeria) studied 
11 children and found the median age to be 11.2 years. 
The youngest among his patients was 6 years at diagno-
sis. The median age at diagnosis in Ile-Ife was similar to 
the global average of 12years.1,6 
 
Recognised trigger factors in SLE include infections, 
medications (antihypertensives and anticonvulsants) and 
hormonal changes1-3. Our patient had culture-positive 
urinary tract infection which was a possible trigger. Fur-
thermore, it was possible that sun exposure contributed 
as a trigger in this instance considering the time of the 
year in the northern part of the country. Generally, the 
disease is thought to result from a combination of hu-
moral and environmental factors in genetically predis-
posed individuals. Human Leucocyte Antigen (HLA) 
class II alleles DR2 and DR3 contribute to disease sus-
ceptibility in some patients as inherited complement 
deficiencies1. 
 
The most frequent presenting symptoms of SLE are pro-
longed fever, malaise weight loss and lymphadenopathy1
-3.  This was not the case with our patient who first pre-
sented with features of nephritis. Renal disease is the 
greatest contributor to morbidity and mortality in paedi-
atric SLE occurring in 60-80% within the first year of 
disease onset1. According to Odetunde et al7, nephritis 
with skin rashes was the first manifestation in a 9- year-
old boy reported to have SLE in Enugu. Likewise in Ile-
Ife5, the mean time of onset of renal disease was 1.22 ± 
0.93 years after onset of systemic illness. 
Our patient had skin rash which was more of vasculiti  
lesions that are not as common as the malar (butterfly) 
rash. The use of cefixime around the time of appearance 
of the rash suggested the possibility of a drug reaction 
but these rash got worse after the withdrawal of the 
drug. Moreso, cephalosporins are not recognized trigge  
factor. Olowu5 had noted that only 3 out of the 11 cases 
had the typical malar rash but none of them had the vas-
culitic rash. It may be that rash (regardless of morph l-
ogy) is not common manifestations in Nigerian children 
with SLE. 
 
Virtually all (10/11) of Olowu’s patients presented with 
arthritis involving one or more site(s), which was not the 
case with our patient who had no evidence of joint in-
volvement. Our patient had echocardiography-confirmed 
moderate pericardial effusion. Pericarditis was the first 
presentation in an 11-year-old girl reported by Elusiyan 
and Olowu in Ile-Ife8. Pericardial effusion is the com-
monest cardiac presentation and is often a cause of  
recurrent chest pain1,6. 
 
The recurrent vomiting and abdominal pain as well as  
ascites (peritoneal serositis) seen in our patient are com-
mon gastro-intestinal manifestations in the disease. Gas-
trointestinal involvement occurs in one-third of patients 
manifesting as serositis, vasculitis, pancreatitis or enteri-
tis and abdominal pain1. Most patients respond to diuret-
ics and steroids and a few may require chloroquine to 
achieve complete resolution of the ascites. Our patient 
improved without the need for chloroquine. Similarly, 
our patient had a stroke which is seen in 8-22% of all 
cases of SLE9. Cerebrovascular event in SLE is due to 
one or combination of accelerated atherosclerosis, va -
culitis, coagulopathy in those that are positive anti-
phospholipid antibodies and or thromboembolism from 
endocarditis1,3,9. The most likely mechanisms in our 
patient is vasculitis in view of her vasculitic rash, nor-
mal coagulation profile (Tab. 1) and the brain CT that 
showed an extensive area of ischemic infarct on the left 
cerebral hemisphere. However,the inability to do lupus 
anticoagulant was a limitation in our evaluation of this 
patient. Other neuropsychiatric symptoms seen in SLE 
include seizures, headache and behavioural abnormali-
ties and may be seen in as many as 90% of SLE cases1-
3,9. 
SLE may presents with pancytopenia or  isolated cell 
line depletion,1 erythrocyte sedimentation rate (ESR) is 
usually elevated depending on disease activity but  
C-reactive protein (CRP) is usually normal except in the 
presence of infection1,3. Our patient had a slightly ele-
vated ESR but her blood count parameter appeared nor-
mal even during the febrile episode. The presence of 
fever or absence of white cell abnormalities, as in our 
patient, does not confirm or exclude respectively the
presence of infection. 
The American College of Rheumatology (ACR) crite-
ria10 for the diagnosis of SLE revised in 1992 require 
that at least 4 out of the 11 criteria should be prsent 
either serially or simultaneously2. Our patient fulfilled 
the following five of the ACR criteria; serositis, nephri-






SLE is a rare disease of the black race with very diverse 
manifestations. Nephritis is the most important manifes-
tation that often leads to its diagnosis in most Nigerian 
series. However, stroke of an unidentified aetiology 
should also make a paediatrician consider SLE like our 




Our patient would have benefitted from renal biopsy, 
ophthalmologic examination and some more specific 
serologic tests which were not done due to logistic chal-
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Dr A. Yahaya in the evaluation of this patient. 
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